DNA Duplex-Based Photodynamic Molecular Beacon for Targeted Killing of Retinoblastoma Cell
Author(s) -
Yanchun Wei,
Cuixia Lu,
Qun Chen,
Da Xing
Publication year - 2016
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.15-18723
Subject(s) - mdmx , molecular beacon , photodynamic therapy , photosensitizer , oligonucleotide , retinoblastoma , flow cytometry , microbiology and biotechnology , dna , chemistry , cancer research , biology , biochemistry , gene , mdm2 , photochemistry , organic chemistry
Retinoblastoma (RB) is the most common primary intraocular malignancy of infancy. An alternative RB treatment protocol is proposed and tested. It is based on a photodynamic therapy (PDT) with a designed molecular beacon that specifically targets the murine double minute x (MDMX) high-expressed RB cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom